Yahoo Malaysia Web Search

Sign In

Search results

  1. www.bachem.comBachem

    Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive ...

  2. en.wikipedia.org › wiki › Bachem_HoldingBachem Holding - Wikipedia

    Bachem Holding AG is a Swiss bio-technology company active in the fields of chemistry, biochemistry and pharmaceuticals.

  3. www.bachem.com › about-bachemAbout Bachem - manufacture of peptides and oligonucleotides

    Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a ...

  4. www.google.com › finance › quoteBACHEM HOLDING AG (BANB) Stock Price & News - Google Finance

    Get the latest BACHEM HOLDING AG (BANB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  5. finance.yahoo.com › quote › BANBBachem Holding AG (BANB.SW) - Yahoo Finance

    Find the latest Bachem Holding AG (BANB.SW) stock quote, history, news and other vital information to help you with your stock trading and investing.

  6. www.bachem.com › about-bachem › investors-and-mediaReports & Presentations - Bachem

    Access past financial reports, download company presentations and watch the replay of our last media and analyst conference.

  7. cdn.bachem.com › wp-content › uploadsANNUAL REPORT - cdn.bachem.com

    BACHEM AT THE CPHI TRADE FAIR IN BARCELONA Bachem presents solutions for scalable oligonucle-otide production and oligonucleotide quality control. JULY 27 SLIGHT SALES GROWTH IN THE FIRST HALF OF 2023 Group sales increase to CHF 239.9˜million (+2.1%, +5.3% in local currencies). EBITDA margin of 21.9%. JUNE 24 BACHEM AT THE AMERICAN PEPTIDE